Clinical Trials
4 trialsNCT07145411 2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
NCT02065869 2023-09-29
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
Bellicum Pharmaceuticals
Phase 1/2 Terminated
NCT03733249 2023-09-26
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Bellicum Pharmaceuticals
Phase 1/2 Terminated
NCT00596999 2012-04-10
HPDSC
Celgene
Unknown